A combination of immunotherapy and chemotherapy could help women with advanced endometrial cancer live longer, NBC News reported March 27.
Oncology
While the new Tisch Cancer Hospital at New York City-based Mount Sinai Hospital will not officially open completely until 2027, new "patient-centric" treatment initiatives, inspired by the promise of the state-of-the-art facility, are already being added to protocols at the…
New breast cancer research out of Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center reveals the cellular, microbial and genomic makeup of cancerous breast tumors differ greatly between white, Black and Asian women. This information "could potentially be used to personalize…
When the FDA updated the 1992 Mammography Quality Standards Act to require patients be informed directly if they have dense breasts, the move may have opened a "Pandora's box," Elisa Port, MD, chief of breast surgery at New York City-based…
Plainsboro, N.J.-based Penn Medicine Princeton Cancer Center received $2.5 million to fund its geriatric oncology program.
The FDA issued draft guidance for clinical trials of oncology drugs in the accelerated approval application.
A recent study found that adding gemcitabine antibiotics with chemotherapy can improve survival rates by 11 percent for patients with a subset of pancreatic cancer.
Seattle-based Fred Hutchinson Cancer Center is set to open its $320 million, 150,000-square foot clinic building.
Boston-based Dana-Farber Cancer Institute researchers found a way to reduce cancer diagnosis time from 32 days to 12 for underserved populations, The ASCO Post reported March 22.
A recent study found progestogen-only contraceptives have a similar risk of breast cancer as combined hormone options, NBC News reported March 21.